Immunic, Inc. Advances MS Trials Amid Financial Update
PremiumCompany AnnouncementsImmunic, Inc. Advances MS Trials Amid Financial Update
5M ago
Immunic reports Q3 EPS (24c), consensus (22c)
Premium
The Fly
Immunic reports Q3 EPS (24c), consensus (22c)
5M ago
Is IMUX a Buy, Before Earnings?
Premium
Pre-Earnings
Is IMUX a Buy, Before Earnings?
5M ago
Immunic price target raised to $13 from $10 at Brookline
PremiumThe FlyImmunic price target raised to $13 from $10 at Brookline
6M ago
B. Riley Reacts to Immunic’s Update on Clinical Benefits of Vidofludimus Calcium   
Premium
Market NewsSponsored
B. Riley Reacts to Immunic’s Update on Clinical Benefits of Vidofludimus Calcium  
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100